Friday, March 29, 2024
ADVT 
National

A look at the rare blood clot condition VIPIT

Darpan News Desk The Canadian Press, 29 Mar, 2021 08:56 PM
  • A look at the rare blood clot condition VIPIT

Federal officials limited the use of Oxford-AstraZeneca's COVID-19 vaccine Monday while it announced an investigation into reported links to a rare blood clot condition known as VIPIT.

The National Advisory Committee on Immunization says the vaccine should not be used by people younger than age of 55, while Health Canada has issued guidelines around what to look for if you suspect you have had an adverse reaction.

Here’s a look at this rare condition.

WHAT IS VIPIT?

VIPIT stands for: Vaccine-Induced Prothrombotic Immune Thrombocytopenia. According to NACI, it is associated with the development of antibodies that "activate" platelets, which stimulate the formation of blood clots.

HOW DANGEROUS IS VIPIT?

The case fatality of VIPIT is approximately 40 per cent, however that may decrease with increased awareness and early treatment.

HOW COMMON IS THIS ADVERSE REACTION?

It’s not clear how common this happens after vaccination but the European Medicines Agency said March 18 it was originally believed to occur once per 1,000,000 people vaccinated with the AstraZeneca vaccine. However, a higher rate of 1 per 100,000 was reported in Germany.

WHO DOES THIS AFFECT?

So far, cases have largely been among women younger than age 55 and mostly emerged between four and 16 days after vaccination. However, a brief for Ontario’s COVID-19 advisory group notes many European countries used more of their initial AstraZeneca doses in women under age 55, which may have skewed the results.

The provincial science table experts add that VIPIT does not appear to be more common in people who have had blood clots before, have a family history of blood clots, have a low platelets, or pregnant women.

ARE THERE KNOWN CASES IN CANADA LINKED TO THE ASTRAZENECA VACCINE?

No.

WHAT ARE THE WARNING SIGNS?

Experts say to look for the following symptoms between four and 20 days after vaccination: a severe headache that does not go away; a seizure; difficulty moving part of your body; new blurry vision that does not go away; difficulty speaking; shortness of breath; chest pain; severe abdominal pain; new severe swelling, pain, or colour change of an arm or a leg.

MORE National ARTICLES

Woman in serious condition after shooting inside Guildford residence in Surrey

Woman in serious condition after shooting inside Guildford residence in Surrey
Frontline officers arrived and located a woman suffering from gunshot wounds. She was transported to the hospital in serious condition.

Woman in serious condition after shooting inside Guildford residence in Surrey

Feds uneasy with Facebook cryptocurrency: Document

Feds uneasy with Facebook cryptocurrency: Document
Officials appeared less concerned about rivals like Bitcoin, which the briefing note says has not played a large role in everyday transactions in Canada for various reasons.

Feds uneasy with Facebook cryptocurrency: Document

What do we know about the AstraZeneca vaccine?

What do we know about the AstraZeneca vaccine?
Experts had maintained the shot is safe and effective — with the benefit of preventing COVID outweighing potential risks — but P.E.I.'s decision to halt use of the vaccine is the latest stumbling block against AstraZeneca.

What do we know about the AstraZeneca vaccine?

Snowbird crash report flags pilot's actions

Snowbird crash report flags pilot's actions
The final flight-safety investigation report released Monday said Capt. Richard MacDougall tried to turn his Tutor jet around and return to the Kamloops Airport after a bird strike caused his engine to stall shortly after takeoff on May 17.

Snowbird crash report flags pilot's actions

Global response needed for economic recovery: PM

Global response needed for economic recovery: PM
At a virtual meeting organized by the United Nations, Trudeau says Canada can’t defeat the novel coronavirus and rebuild its economy unless all countries have the resources to recover.

Global response needed for economic recovery: PM

Liberals earmark $250M for rural transit

Liberals earmark $250M for rural transit
Federal infrastructure programs that help build or update transit systems have provided money to rural projects, but Infrastructure Minster Catherine McKenna noted they don't have a dedicated funding stream.

Liberals earmark $250M for rural transit